Remdesivir in The Treatment of COVID-19 #MMPMID33350698
Rosenberg K
Am J Nurs 2021[Jan]; 121 (1): 55 PMID33350698show ga
According to this study: The antiviral remdesivir is superior to placebo in the treatment of patients hospitalized with COVID-19.A variety of therapeutic approaches are needed to continue to improve outcomes in COVID-19 patients.